Univariate tests. by Yan Zhang (8098)

<i>Ctsz</i>^{<i>−/−</i>} mice have higher lung burden and earlier spleen dissemination during acute infection followed by greater chronic inflammation and mortality risk.... by Rachel K. Meade (22216529)

Subjects:

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

BAPC prediction of PCOS burden in the next 20 years. by Jiacheng Zhang (3597089)

Global and regional burden of PCOS from 1990 to 2019. by Jiacheng Zhang (3597089)

Increased number of parasites per vacuole in ALIXKD cells. by Javier Rosero (22258517)

Placebo test. by Le Zhu (1771669)

Subjects:

Somatic symptom burden, depression, and anxiety scores of the patients with acute and chronic TMD pain. by Adrian Ujin Yap (20623536)

Subjects:

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Dose dependent mutation burden in wild-type and DNA repair mutants. by Bettina Meier (274833)

Tumor volume increase over time. by Jimmy Sundblom (3797785)

FFD – interactive effect, original fibrosis burden. by Åshild Telle (22794721)

FFD – main effect, original fibrosis burden. by Åshild Telle (22794721)

Robustness test—change variable. by Yuanquan Lu (17125093)

Robustness test—GLM model. by Yuanquan Lu (17125093)

Burden of disease of Bipolar Affective Disorder expressed in DALYs. by Alberto Rodríguez-Lorenzana (8723562)

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). Percentages (%) of increases or decreases (%) based on the Mann-Kendall test and statistically significant (<i>p</i> < 0.05) and non-significant (p > 0.05) values. by Oswaldo Maillard (20660661)

Test results of GFRP confined concrete specimens. by Qingwen Li (1510687)

Subjects:

Heterogeneity tests in local RD: Different firm risks. by Vivek Astvansh (14310090)